Literature DB >> 16522421

Maternal morbidity after maternal-fetal surgery.

Kirstin Golombeck1, Robert H Ball, Hanmin Lee, Jody A Farrell, Diana L Farmer, Volker R Jacobs, Mark A Rosen, Roy A Filly, Michael R Harrison.   

Abstract

OBJECTIVE: There is a paucity of published data on the maternal risks of fetal surgical interventions. We analyzed maternal morbidity and mortality that were associated with different types of fetal intervention (open hysterotomy, various endoscopic procedures and percutaneous techniques) to quantify this risk. STUDY
DESIGN: We performed a retrospective evaluation of a continuous series of 187 cases that had been performed between July 1989 and May 2003 at the Fetal Treatment Center, a highly specialized interdisciplinary center for fetal surgery at the University of California, San Francisco. The primary outcome was the frequency of maternal morbidity for open, endoscopic, and percutaneous procedures to access the fetus.
RESULTS: There were 187 pregnant women with confirmed major fetal malformations who were candidates for intrauterine fetal intervention. Maternal-fetal surgery was performed in 87 cases by open hysterotomy, in 69 cases by endoscopic procedures, and in 31 cases by percutaneous techniques. There were no maternal deaths, but significant short-term morbidity was observed. There were no significant differences in the incidence of premature rupture of membranes, pulmonary edema, placental abruption, postoperative vaginal bleeding, preterm delivery, or interval from maternal-fetal surgery to delivery between endoscopic procedures and open surgery. Complications were significantly less in the percutaneous ultrasound-guided procedures. Endoscopic procedures, even with a laparotomy, showed statistically significantly less morbidity compared with the open hysterotomy group regarding cesarean delivery as delivery mode (94.8% vs 58.8%; P < .001), requirement for intensive care unit stay (1.4% vs 26.4%; P < .001), length of hospital stay (7.9 vs 11.9 days; P = .001), and requirement for blood transfusions (2.9% vs 12.6%; P = .022). Chorion-amnion membrane separation (64.7% vs 20.3%; P < .001) was seen more often in the endoscopy group.
CONCLUSION: Short-term morbidities include increased rates of cesarean birth, treatment in intensive care, prolonged hospitalization, and blood transfusion, all of which were more common with hysterotomy compared with other techniques. Maternal-fetal surgery can be performed without maternal death. Results from this study provide helpful data for counseling prospective patients.

Entities:  

Mesh:

Year:  2006        PMID: 16522421     DOI: 10.1016/j.ajog.2005.10.807

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

Review 1.  Fetal surgical intervention: progress and perspectives.

Authors:  Jesse D Vrecenak; Alan W Flake
Journal:  Pediatr Surg Int       Date:  2013-04-04       Impact factor: 1.827

2.  Fetal intervention increases maternal T cell awareness of the foreign conceptus and can lead to immune-mediated fetal demise.

Authors:  Marta Wegorzewska; Amar Nijagal; Charissa M Wong; Tom Le; Ninnia Lescano; Qizhi Tang; Tippi C MacKenzie
Journal:  J Immunol       Date:  2014-01-10       Impact factor: 5.422

Review 3.  Advances in fetal surgery.

Authors:  Kathryn M Maselli; Andrea Badillo
Journal:  Ann Transl Med       Date:  2016-10

Review 4.  Biomaterials in fetal surgery.

Authors:  Sally M Winkler; Michael R Harrison; Phillip B Messersmith
Journal:  Biomater Sci       Date:  2019-05-17       Impact factor: 6.843

5.  Preclinical testing and optimization of a novel fetal micropacemaker.

Authors:  Yaniv Bar-Cohen; Gerald E Loeb; Jay D Pruetz; Michael J Silka; Catalina Guerra; Adriana N Vest; Li Zhou; Ramen H Chmait
Journal:  Heart Rhythm       Date:  2015-03-14       Impact factor: 6.343

6.  Anesthesia for in utero repair of myelomeningocele.

Authors:  Marla Ferschl; Robert Ball; Hanmin Lee; Mark D Rollins
Journal:  Anesthesiology       Date:  2013-05       Impact factor: 7.892

7.  Paediatrics-based fetal care: unanswered ethical questions.

Authors:  Stephen D Brown; Anne D Lyerly; Margaret O Little; John D Lantos
Journal:  Acta Paediatr       Date:  2008-10-13       Impact factor: 2.299

8.  Fetal interventions for congenital heart disease in Brazil.

Authors:  Simone Rolim Fernandes Fontes Pedra; Cleisson Fábio Andrioli Peralta; Luciana Crema; Ieda Bosisio Jatene; Rodrigo Nieckel da Costa; Carlos Augusto Cardoso Pedra
Journal:  Pediatr Cardiol       Date:  2013-09-13       Impact factor: 1.655

9.  A critique of the 'fetus as patient'.

Authors:  Anne Drapkin Lyerly; Margaret Olivia Little; Ruth R Faden
Journal:  Am J Bioeth       Date:  2008-07       Impact factor: 11.229

Review 10.  In utero hematopoietic cell transplantation for hemoglobinopathies.

Authors:  S Christopher Derderian; Cerine Jeanty; Mark C Walters; Elliott Vichinsky; Tippi C MacKenzie
Journal:  Front Pharmacol       Date:  2015-01-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.